Microtubules
are dynamic structures that form spindle
fibers during
cell division; pharmacological inhibition of microtubule dynamics
arrests cells in mitosis, leading to apoptosis, and they have been
extensively used to treat various cancers. However, the efficacy of
such drugs is often limited by multidrug resistance. This study synthesized
and evaluated 30 novel derivatives of podophyllotoxin, a natural antimitotic
compound, for their antiproliferative activities. Compound SSE1806
exhibited the most potent antiproliferative activity with GI50 values ranging from 1.29 ± 0.01 to 21.15 ± 2.1 μM
in cancer cell lines of different origins; it directly inhibited microtubule
polymerization, causing aberrant mitosis and G2/M arrest. Prolonged
treatment with SSE1806 increased p53 expression, induced cell death
in monolayer cultures, and reduced the growth of mouse- and patient-derived
human colon cancer organoids. Importantly, SSE1806 overcame multidrug
resistance in a cell line overexpressing MDR-1. Thus, SSE1806 represents
a potential anticancer agent that can overcome multidrug resistance.